We provide you with 20 years of free, institutional-grade data for ARWR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ARWR. Explore the full financial landscape of ARWR stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 879407 | ARWR | 10-Q | Url |
| 2025-05-12 | 879407 | ARWR | 10-Q | Url |
| 2025-02-10 | 879407 | ARWR | 10-Q | Url |
| 2024-11-26 | 879407 | ARWR | 10-K | Url |
| 2024-08-08 | 879407 | ARWR | 10-Q | Url |
| 2024-05-09 | 879407 | ARWR | 10-Q | Url |
| 2024-02-06 | 879407 | ARWR | 10-Q | Url |
| 2023-11-29 | 879407 | ARWR | 10-K | Url |
| 2023-08-07 | 879407 | ARWR | 10-Q | Url |
| 2023-05-02 | 879407 | ARWR | 10-Q | Url |
| 2023-02-06 | 879407 | ARWR | 10-Q | Url |
| 2022-11-28 | 879407 | ARWR | 10-K | Url |
| 2022-08-04 | 879407 | ARWR | 10-Q | Url |
| 2022-05-10 | 879407 | ARWR | 10-Q | Url |
| 2022-02-02 | 879407 | ARWR | 10-Q | Url |
| 2021-11-22 | 879407 | ARWR | 10-K | Url |
| 2021-08-05 | 879407 | ARWR | 10-Q | Url |
| 2021-05-04 | 879407 | ARWR | 10-Q | Url |
| 2021-02-04 | 879407 | ARWR | 10-Q | Url |
| 2020-11-23 | 879407 | ARWR | 10-K | Url |
| 2020-08-05 | 879407 | ARWR | 10-Q | Url |
| 2020-05-07 | 879407 | ARWR | 10-Q | Url |
| 2020-02-05 | 879407 | ARWR | 10-Q | Url |
| 2019-11-25 | 879407 | ARWR | 10-K | Url |
| 2019-08-05 | 879407 | ARWR | 10-Q | Url |
| 2019-05-08 | 879407 | ARWR | 10-Q | Url |
| 2019-02-07 | 879407 | ARWR | 10-Q | Url |
| 2018-12-11 | 879407 | ARWR | 10-K | Url |
| 2018-08-07 | 879407 | ARWR | 10-Q | Url |
| 2018-05-08 | 879407 | ARWR | 10-Q | Url |
| 2018-02-09 | 879407 | ARWR | 10-Q | Url |
| 2017-12-12 | 879407 | ARWR | 10-K | Url |
| 2017-08-03 | 879407 | ARWR | 10-Q | Url |
| 2017-05-03 | 879407 | ARWR | 10-Q | Url |
| 2017-02-06 | 879407 | ARWR | 10-Q | Url |
| 2016-12-14 | 879407 | ARWR | 10-K | Url |
| 2016-08-09 | 879407 | ARWR | 10-Q | Url |
| 2016-05-10 | 879407 | ARWR | 10-Q | Url |
| 2016-02-09 | 879407 | ARWR | 10-Q | Url |
| 2015-12-14 | 879407 | ARWR | 10-K | Url |
| 2015-08-04 | 879407 | ARWR | 10-Q | Url |
| 2015-05-11 | 879407 | ARWR | 10-Q | Url |
| 2015-02-09 | 879407 | ARWR | 10-Q | Url |
| 2014-11-25 | 879407 | ARWR | 10-K | Url |
| 2014-08-12 | 879407 | ARWR | 10-Q | Url |
| 2014-05-06 | 879407 | ARWR | 10-Q | Url |
| 2014-02-04 | 879407 | ARWR | 10-Q | Url |
| 2013-12-18 | 879407 | ARWR | 10-K | Url |
| 2013-08-07 | 879407 | ARWR | 10-Q | Url |
| 2013-05-09 | 879407 | ARWR | 10-Q | Url |
| 2013-02-13 | 879407 | ARWR | 10-Q | Url |
| 2012-12-28 | 879407 | ARWR | 10-K | Url |
| 2012-08-13 | 879407 | ARWR | 10-Q | Url |
| 2012-05-08 | 879407 | ARWR | 10-Q | Url |
| 2012-02-09 | 879407 | ARWR | 10-Q | Url |
| 2011-12-20 | 879407 | ARWR | 10-K | Url |
| 2011-08-08 | 879407 | ARWR | 10-Q | Url |
| 2011-05-12 | 879407 | ARWR | 10-Q | Url |
| 2011-02-10 | 879407 | ARWR | 10-Q | Url |
| 2010-12-22 | 879407 | ARWR | 10-K | Url |
| 2010-08-12 | 879407 | ARWR | 10-Q | Url |
| 2010-05-13 | 879407 | ARWR | 10-Q | Url |
| 2010-02-11 | 879407 | ARWR | 10-Q | Url |
| 2009-12-28 | 879407 | ARWR | S-1 | Url |
| 2009-12-22 | 879407 | ARWR | 10-K | Url |
| 2009-08-14 | 879407 | ARWR | S-1 | Url |
| 2009-08-10 | 879407 | ARWR | 10-Q | Url |
| 2009-05-15 | 879407 | ARWR | 10-Q | Url |
| 2009-02-09 | 879407 | ARWR | 10-Q | Url |
| 2008-12-15 | 879407 | ARWR | 10-K | Url |
| 2008-08-11 | 879407 | ARWR | 10-Q | Url |
| 2008-05-12 | 879407 | ARWR | 10-Q | Url |
| 2008-02-11 | 879407 | ARWR | 10-Q | Url |
| 2007-12-14 | 879407 | ARWR | 10-K | Url |
| 2007-08-09 | 879407 | ARWR | 10-Q | Url |
| 2007-05-10 | 879407 | ARWR | 10-Q | Url |
| 2007-02-09 | 879407 | ARWR | 10-Q | Url |
| 2006-12-14 | 879407 | ARWR | 10-K | Url |
| 2006-08-09 | 879407 | ARWR | 10-Q | Url |
| 2006-05-10 | 879407 | ARWR | 10-Q | Url |
| 2006-02-09 | 879407 | ARWR | 10-Q | Url |
| 1998-08-07 | 879407 | ARWR | 10-Q | Url |
Arrowhead Pharmaceuticals, Inc(NASDAQ:ARWR) 
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...
Website: http://arrowheadpharma.com
Founded: 1989
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ARWR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.